Article
SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer.
PloS one - 1 Jan 2013
Huang Liu, Zhang Tao, Xie Conghua, Liao Xin, Yu Qianqian, Feng Jueping, Ma Hong, Dai Jing, Li Min, Chen Jigui, Zang Aihua, Wang Qian, Ge Shuwang, Qin Kai, Cai Juan, Yuan Xianglin
Abstract excerpt
BACKGROUND: Rapid response to chemotherapy in metastatic colorectal cancer (mCRC) patients (response within 12 weeks of chemotherapy) may increase the chance of complete resection and improved survival. Few molecular markers predict irinotecan-induced rapid response and survival. Single-nucleotide polymorphisms (SNPs) in solute carrier genes are reported to correlate with the variable pharmacokinetics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
